MAXIMUS, Inc. (NYSE:MMS) – Equities research analysts at First Analysis boosted their Q2 2018 earnings per share (EPS) estimates for MAXIMUS in a report released on Thursday. First Analysis analyst F. Sparacino now expects that the health services provider will post earnings per share of $0.85 for the quarter, up from their previous forecast of $0.75. First Analysis also issued estimates for MAXIMUS’s Q3 2018 earnings at $0.85 EPS, FY2018 earnings at $3.50 EPS, Q1 2019 earnings at $0.93 EPS and FY2019 earnings at $3.87 EPS.
MAXIMUS (NYSE:MMS) last released its quarterly earnings results on Thursday, November 9th. The health services provider reported $0.81 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.77 by $0.04. MAXIMUS had a net margin of 8.99% and a return on equity of 22.93%. The company had revenue of $620.90 million for the quarter, compared to analysts’ expectations of $606.86 million.
Shares of MAXIMUS (NYSE:MMS) opened at $63.79 on Monday. MAXIMUS has a 12 month low of $55.18 and a 12 month high of $72.71. The stock has a market cap of $4,160.58, a PE ratio of 18.99, a price-to-earnings-growth ratio of 2.39 and a beta of 1.21. The company has a current ratio of 2.57, a quick ratio of 2.08 and a debt-to-equity ratio of 0.01.
Hedge funds have recently made changes to their positions in the business. Steward Partners Investment Advisory LLC acquired a new position in MAXIMUS during the fourth quarter valued at approximately $169,000. Intl Fcstone Inc. acquired a new position in MAXIMUS during the second quarter valued at approximately $201,000. Capital One National Association acquired a new position in MAXIMUS during the fourth quarter valued at approximately $213,000. OLD National Bancorp IN acquired a new position in MAXIMUS during the third quarter valued at approximately $246,000. Finally, Cubist Systematic Strategies LLC lifted its position in MAXIMUS by 16.0% during the second quarter. Cubist Systematic Strategies LLC now owns 3,969 shares of the health services provider’s stock valued at $249,000 after buying an additional 546 shares in the last quarter. 96.44% of the stock is currently owned by hedge funds and other institutional investors.
In related news, General Counsel David Francis sold 1,373 shares of the firm’s stock in a transaction that occurred on Friday, November 17th. The shares were sold at an average price of $65.35, for a total value of $89,725.55. Following the sale, the general counsel now directly owns 13,617 shares of the company’s stock, valued at $889,870.95. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Russell A. Beliveau sold 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, January 2nd. The stock was sold at an average price of $71.73, for a total transaction of $71,730.00. The disclosure for this sale can be found here. Insiders sold 67,517 shares of company stock worth $4,653,302 over the last three months. Corporate insiders own 3.10% of the company’s stock.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, February 28th. Investors of record on Thursday, February 15th will be given a $0.045 dividend. The ex-dividend date of this dividend is Wednesday, February 14th. This represents a $0.18 annualized dividend and a dividend yield of 0.28%. MAXIMUS’s dividend payout ratio is presently 5.36%.
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.